Structure-activity relationship investigation of coumarin-chalcone hybrids with diverse side-chains as acetylcholinesterase and butyrylcholinesterase inhibitors
- PMID: 29934672
- PMCID: PMC6309603
- DOI: 10.1007/s11030-018-9839-y
Structure-activity relationship investigation of coumarin-chalcone hybrids with diverse side-chains as acetylcholinesterase and butyrylcholinesterase inhibitors
Abstract
Chalcones containing tertiary amine side-chains have potent activity as acetylcholinesterase (AChE) inhibitors. However, the effects of the location of the tertiary amine groups as well as of other groups on AChE and butyrylcholinesterase (BChE) activity have not been reported. Here, we report the synthesis and testing of 36 new coumarin-chalcone hybrids (5d-7j, 9d-11f, 12k-13m) against AChE and BChE. The nature and position of the chalcone substituents had major effects on inhibitory activity as well as selectivity for AChE over BChE. Compounds with para-substituted chalcone fragments in which the substituents were choline-like had potent activity against AChE and poor activity against BChE, while ortho-substituted analogs exhibited an opposite effect. Replacement of the terminal amine groups by amide, alkyl or alkenyl groups abrogated activity. Compound 5e showed potent inhibitory activity [Formula: see text]) and good selectivity for AChE over BChE (ratio 27.4), and a kinetic study showed that 5e exhibited mixed-type inhibition against AChE. Computational docking results indicate that 5e binds to Trp 279, Tyr334 and Trp 84 in AChE, but only to Trp 82 in BChE. Overall, the results show that coumarin-chalcone hybrids with choline-like side-chains have promising activity and selectivity against AChE and be promising therapeutic leads for Alzheimer's disease.
Keywords: Chalcone; Cholinesterase inhibitors; Coumarin; Structure–activity relationship; Tertiary amine group.
Figures




Similar articles
-
Structure-activity study of fluorine or chlorine-substituted cinnamic acid derivatives with tertiary amine side chain in acetylcholinesterase and butyrylcholinesterase inhibition.Drug Dev Res. 2019 Jun;80(4):438-445. doi: 10.1002/ddr.21515. Epub 2019 Jan 24. Drug Dev Res. 2019. PMID: 30680760
-
Novel ferulic amide derivatives with tertiary amine side chain as acetylcholinesterase and butyrylcholinesterase inhibitors: The influence of carbon spacer length, alkylamine and aromatic group.Eur J Med Chem. 2017 Jan 27;126:810-822. doi: 10.1016/j.ejmech.2016.12.003. Epub 2016 Dec 2. Eur J Med Chem. 2017. PMID: 27951489
-
Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel Coumarin-Triazole-Isatin Hybrids as Selective Butyrylcholinesterase Inhibitors.Molecules. 2025 May 11;30(10):2121. doi: 10.3390/molecules30102121. Molecules. 2025. PMID: 40430294 Free PMC article.
-
Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.Mini Rev Med Chem. 2018;18(8):711-716. doi: 10.2174/1389557517666170713114039. Mini Rev Med Chem. 2018. PMID: 28714400 Review.
-
Structural Modifications on Chalcone Framework for Developing New Class of Cholinesterase Inhibitors.Int J Mol Sci. 2022 Mar 14;23(6):3121. doi: 10.3390/ijms23063121. Int J Mol Sci. 2022. PMID: 35328542 Free PMC article. Review.
Cited by
-
Molecular Modeling and In Vitro Evaluation of Thioureas and Arylthioureas as Urease Inhibitors.ACS Omega. 2025 May 22;10(21):21795-21812. doi: 10.1021/acsomega.5c01648. eCollection 2025 Jun 3. ACS Omega. 2025. PMID: 40488039 Free PMC article.
-
Facile indazole-endowed thiadiazole hybrid derivatives as antibacterial, anti-diabetic and thymidine phosphorylase inhibitors: An insight to experimental, in-vitro biological potential and computational approaches.Saudi Pharm J. 2025 Jul 8;33(4):20. doi: 10.1007/s44446-025-00003-9. Saudi Pharm J. 2025. PMID: 40627252 Free PMC article.
-
ADME analysis, metabolic prediction, and molecular docking of lipoic acid with SARS-CoV-2 Omicron spike protein.Sci Rep. 2025 Jul 8;15(1):24386. doi: 10.1038/s41598-025-93121-2. Sci Rep. 2025. PMID: 40628911 Free PMC article.
-
Exploring the Versatility of Azine Derivatives: A Comprehensive Review on Synthesis and Biological Applications.Mini Rev Med Chem. 2025;25(6):425-439. doi: 10.2174/0113895575363243241129100845. Mini Rev Med Chem. 2025. PMID: 39810540 Free PMC article. Review.
-
Cracking the code: the clinical and molecular impact of aminopyridines; a review (2019-2024).RSC Adv. 2025 Jan 8;15(1):688-711. doi: 10.1039/d4ra07438f. eCollection 2025 Jan 2. RSC Adv. 2025. PMID: 39781020 Free PMC article. Review.
References
-
- Association A. Alzheimer’s disease facts and figures. Alzheimer’s Dement. 2017;13:325–373. doi: 10.1016/j.jalz.2017.02.001. - DOI
-
- Blanco-Silvente L, Castells X, Saez M, Barceló MA, GarreOlmo J, Vilalta-Franch J, Capellà D. Discontinuation, efficacy, and safety of cholinesterase inhibitors for Alzheimer’s disease: a meta-analysis and meta-regression of 43 randomized clinical trials enrolling 16106 patients. Int J Neuropsychoph. 2017;20:519–528. doi: 10.1093/ijnp/pyx012. - DOI - PMC - PubMed
-
- Gurbuz AS, Ozturk S, Acar E, Cagan Efe S, Akgun T, Kilicgedik A, Guler A, Kirma C. Acquired long QT syndrome and Torsades de Pointes related to donepezil use in a patient with Alzheimer disease. Egypt Heart J. 2016;68:197–199. doi: 10.1016/j.ehj.2015.07.004. - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous